Cardiology

FDA Outlines Plan for Increasing Nonprescription Drug Availability




The draft guidance, Innovative Approaches for Nonprescription Drug Products, applies to drugs under the New Drug Application (NDA) process and “is intended to extend that NDA pathway to include therapeutic indications that have not, historically, been available for use without a prescription,” said Gottlieb in a press statement.

Source link




Related posts

Protective mechanism of artemisinin on rat bone marrow-derived mesenchymal stem cells against apoptosis induced by hydrogen peroxide via activation of c-Raf-Erk1/2-p90rsk-CREB pathway.

Newsemia

Technology Update: Pipeline Medical Gets First-In-Man TMVR Implant & Gore Acquisition

Newsemia

Impact of the Discordance Between the American College of Cardiology/American Heart Association and American Diabetes Association Recommendations on Hypertension in Patients With Diabetes Mellitus in the United States [Guidelines Conversation]

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy